Repository logo
 

Differential genomic imprinting regulates paracrine and autocrine roles of IGF2 in mouse adult neurogenesis.


Type

Conference Object

Change log

Authors

Ferrón, SR 
Radford, EJ 
Domingo-Muelas, A 
Kleine, I 
Ramme, A 

Abstract

Genomic imprinting is implicated in the control of gene dosage in neurogenic niches. Here we address the importance of Igf2 imprinting for murine adult neurogenesis in the subventricular zone (SVZ) and in the subgranular zone (SGZ) of the hippocampus in vivo. In the SVZ, paracrine IGF2 is a cerebrospinal fluid and endothelial-derived neurogenic factor requiring biallelic expression, with mutants having reduced activation of the stem cell pool and impaired olfactory bulb neurogenesis. In contrast, Igf2 is imprinted in the hippocampus acting as an autocrine factor expressed in neural stem cells (NSCs) solely from the paternal allele. Conditional mutagenesis of Igf2 in blood vessels confirms that endothelial-derived IGF2 contributes to NSC maintenance in SVZ but not in the SGZ, and that this is regulated by the biallelic expression of IGF2 in the vascular compartment. Our findings indicate that a regulatory decision to imprint or not is a functionally important mechanism of transcriptional dosage control in adult neurogenesis.

Description

Keywords

Animals, Autocrine Communication, Endothelial Cells, Enzyme-Linked Immunosorbent Assay, Gene Dosage, Gene Expression Regulation, Developmental, Gene Knockdown Techniques, Genomic Imprinting, Hippocampus, Immunohistochemistry, Insulin-Like Growth Factor II, Lateral Ventricles, Mice, Neural Stem Cells, Neurogenesis, Olfactory Bulb, Paracrine Communication

Journal Title

Nat Commun

Conference Name

Journal ISSN

1043-0342
2041-1723

Volume Title

6

Publisher

Springer Science and Business Media LLC
Sponsorship
Medical Research Council (MR/J001597/1)
Biotechnology and Biological Sciences Research Council (BB/H003312/1)
Wellcome Trust (095606/Z/11/Z)
This work was supported by grants from Ministerio de Economía y Competitividad (SAF2012-40107), Generalitat Valenciana (Programa ACOMP2014-258) and Fundación BBVA to SRF and grants from the MRC, Wellcome Trust and EU FP7 Ingenium Training Network to AFS. AW and TRM were supported by the Association for International Cancer Research and Medical Research Council, UK.SRF was a recipient of a Herchel-Smith fellowship and currently is a Ramón y Cajal investigator. ADM is funded by a Spanish FPU fellowship program of the Ministerio de Educación, Cultura y Deporte. AR was from the Erasmus Placement Program.